267 related articles for article (PubMed ID: 25346302)
1. Refractory bullous pemphigoid leaving numerous milia during recovery.
Uchida S; Oiso N; Koga H; Ishii N; Okahashi K; Matsuda H; Hashimoto T; Kawada A
J Dermatol; 2014 Nov; 41(11):1003-5. PubMed ID: 25346302
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid with prominent milium formation.
Tsuruta D; Brzezinski P; Koga H; Ohata C; Furumura M; Hashimoto T
Acta Dermatovenerol Croat; 2013; 21(1):35-8. PubMed ID: 23683484
[TBL] [Abstract][Full Text] [Related]
3. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
Front Immunol; 2019; 10():1934. PubMed ID: 31474998
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
5. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
[TBL] [Abstract][Full Text] [Related]
6. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
[TBL] [Abstract][Full Text] [Related]
7. Milia within resolving bullous pemphigoid lesions.
Amin S; Fiore CT; Paek SY
Proc (Bayl Univ Med Cent); 2019 Jan; 32(1):90-92. PubMed ID: 30956594
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
[TBL] [Abstract][Full Text] [Related]
9. Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases.
Martinez-De Pablo MI; González-Enseñat MA; Vicente A; Gilaberte M; Mascaró JM
Arch Dermatol; 2007 Feb; 143(2):215-20. PubMed ID: 17310001
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
Gammon WR; Briggaman RA; Woodley DT; Heald PW; Wheeler CE
J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):820-32. PubMed ID: 6392361
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample.
Vernal S; Oliveira EV; Bueno Filho R; Julio TA; Donadi EA; Turatti A; Ishii N; Hashimoto T; Roselino AM
An Bras Dermatol; 2022; 97(4):435-442. PubMed ID: 35637051
[TBL] [Abstract][Full Text] [Related]
13. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
14. [Epidermolysis bullosa acquisita with Brunsting-Perry type pemphigoid: Diagnostic and therapeutic difficulties].
Henry J; Bursztejn AC; Bonhomme A; Cuny JF; Mitcov M; Blanchard-Laumonnier E; Schmutz JL
Ann Dermatol Venereol; 2020; 147(6-7):439-445. PubMed ID: 32245657
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180.
Pas HH; Kloosterhuis GJ; Heeres K; van der Meer JB; Jonkman MF
J Invest Dermatol; 1997 Apr; 108(4):423-9. PubMed ID: 9077469
[TBL] [Abstract][Full Text] [Related]
16. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
17. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
18. Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases.
Janela R; Ishii N; Castel M; Jouen F; Cellier L; Courville P; Joly P; Hébert V
Front Immunol; 2023; 14():1134720. PubMed ID: 37006294
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
20. Two cases of childhood bullous pemphigoid.
Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
